Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
0.3361
+0.0097 (2.97%)
At close: Jan 16, 2026, 4:00 PM EST
0.3417
+0.0056 (1.67%)
After-hours: Jan 16, 2026, 7:42 PM EST
Tevogen Bio Holdings Employees
Tevogen Bio Holdings had 18 employees as of December 31, 2024.
Employees
18
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,745,383
Market Cap
66.78M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TVGN News
- 5 days ago - Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025 - GlobeNewsWire
- 26 days ago - Tevogen CEO Donates Shares to Support Education for Underprivileged Children - GlobeNewsWire
- 4 weeks ago - Tevogen CEO Donates Personal Shares to Support Local Fire Department - GlobeNewsWire
- 5 weeks ago - Tevogen CEO Supports Local Law Enforcement with Personal Contribution of 230,000 Company's Shares of Common Stock - GlobeNewsWire
- 5 weeks ago - Tevogen Celebrates Board Member Dr. Curtis Patton, Honored by Yale University for Distinguished Career and Lasting Contributions to Medical Education and Equity in Medicine - GlobeNewsWire
- 5 weeks ago - Tevogen Recognized on 2025 NJBIZ Power List Amid Growth and Multi-Billion-Dollar Revenue Outlook - GlobeNewsWire
- 2 months ago - Tevogen Highlights Continued Capital Efficiency Following Filing of Q3 2025 Form 10-Q - GlobeNewsWire
- 2 months ago - Tevogen Reports Major Clinical Milestone: Expands HLA Coverage of its Investigational Precision T Cell Therapy for Acute and Long COVID - GlobeNewsWire